FRITSCH加强型新产品简介

本文由 北京飞驰科学仪器有限公司 整理汇编

2016-05-02 00:00 231阅读次数

收藏 评价 举报

• 分享

立即下载

参与评论

评论

登录后参与评论

登录

获取验证码

我已经阅读并接受《仪器网服务协议》

立即登录

更多资料

• FRITSCH加强型新产品简介

  FRITSCH加强型新产品简介[详细]

  2016-05-02 00:00

  安装说明

  |

  • 
  • 
  • 
  • 

• Fritsch可变速高速旋转粉碎机/仪 加强型产品样册

  Fritsch可变速高速旋转粉碎机/仪 加强型产品样册[详细]

  2016-10-18 14:48

  课件

  |

  • 
  • 
  • 
  • 

• FRITSCH 微型行星式高能球磨机（加强型）产品样册

  FRITSCH 微型行星式高能球磨机（加强型）产品样册[详细]

  2016-10-19 17:40

  产品样册

  |

  • 
  • 
  • 
  • 

• 德国FRITSCH（飞驰）行星式球磨机加强型彩页

  本彩页是关于德国FRITSCH（飞驰）公司生产的行星式球磨机加强型系列的详细说明和介绍。[详细]

  2018-08-27 10:00

  产品样册

  |

  • 
  • 
  • 
  • 

• 德国FRITSCH（飞驰）P-13 加强型圆盘式研磨机产品样册

  德国FRITSCH（飞驰）P-13 加强型圆盘式研磨机产品样册[详细]

  2024-09-18 19:21

  应用文章

  |

  • 
  • 
  • 
  • 

• Fritsch双罐行星式球磨机/仪 加强型产品样册

  Fritsch双罐行星式球磨机/仪 加强型产品样册[详细]

  2016-10-18 14:48

  期刊论文

  |

  • 
  • 
  • 
  • 

• 德国FRITSCH（飞驰）P-1加强型颚式破碎机产品样册

  德国FRITSCH（飞驰）P-1加强型颚式破碎机产品样册[详细]

  2024-09-29 02:28

  操作手册

  |

  • 
  • 
  • 
  • 

• 德国FRITSCH P7 小型行星式球磨机/仪加强型产品样册

  德国FRITSCH P7 小型行星式球磨机/仪加强型产品样册[详细]

  2024-09-14 19:11

  标准

  |

  • 
  • 
  • 
  • 

• 国家ZD新产品

  国家ZD新产品[详细]

  2003-04-07 00:00

  报价单

  |

  • 
  • 
  • 
  • 

• 欧司朗LED新产品

  欧司朗2014年新产品。[详细]

  2018-10-30 10:00

  产品样册

  |

  • 
  • 
  • 
  • 

• socorex移液器新产品

  瑞士SOCOREX成立于1940年，是从事高精密液体操作产品的研发，生产及经营的专业厂家。配备完善的技术支持，维修和校准服务。产品包括：手动，电动移液器，多道移液器，瓶口配液器、移液管控制器、连续分液器、连续注射器，特殊用途移液器及各产品完备的附件系统。可以实现液体计量、定量给料，转移传输、等量分配和液体注射等多项液体操作功能。瑞士SOCOREX公司通过对精密液体操作产品及优质服务的高度关注，通过了ISO9001和ISO13485质量管理体系认证。所有产品通过ISO8655，GLP，GMP和NCCLS认证文件，同时所有产品出厂前进行严格QC认证，每个产品都有单独出具的报告文件。SOCOREX每个精密仪器具备有其自身的序列号并通过了严格的品控测试，独立的第三方认证。“一步式解决方案”时SOCOREX服务ZX的格言。依据ISO17025标准，SOCOREX服务ZX提供了性的维修和校准程序。[详细]

  2024-10-10 02:50

  产品样册

  |

  • 
  • 
  • 
  • 

• FRITSCH产品应用手册

  FRITSCH产品应用手册[详细]

  2015-12-07 00:00

  报价单

  |

  • 
  • 
  • 
  • 

• 行星式球磨机·加强型 - 彩页

  行星式球磨机·加强型 - 彩页[详细]

  2016-04-27 00:00

  期刊论文

  |

  • 
  • 
  • 
  • 

• Wilkerson过滤器，Wilkerson新产品

  Wilkerson过滤器，Wilkerson新产品Wilkerson威尔克森过滤器由简体、不锈钢滤网、排污部分、传动装置及电气控制部分组成。过滤器工作时，待过滤的水由水口过滤器流Wilkerson威尔克森过滤器经滤网，通过出口进入用户所须的管道进行工艺循环，水中的颗粒杂质被截留在滤网内部。如此不断的循环，被截留下来的颗粒越来越多，过滤速度越来越慢，而进口的污水仍源源不断地进入，滤孔会越来越小，由此在进、出口之间产生压力差，当大度差达到设定值时，差压变送器将电信号传送到控制器，控制系统启动驱动马达通过传动组件带动轴转动，同时排污口打开，由排污口排出，当滤网清洗完毕后，压差降到Z小值，系统返回到初始过滤状，系统正常运行。Wilkerson威尔克森过滤器由壳体、多元滤芯、反冲洗机构、和差压控制器等部分组成。壳体内的横隔板将其内腔分为上、下两腔，上腔内配有多个过滤芯，这样充分利用了过滤空间，显着缩小了过滤器的体积，下腔内安装有反冲洗吸盘。工作时，浊液经入口进入过滤器下腔，又经隔板孔进入滤芯的内腔。大于过滤芯缝隙的杂质被截留，净液穿过缝隙到达上腔，Z后从出口送出。新产品查看新的Wilkerson产品！查看Wilkerson的R90系列。90系列允许在不使用管道连接器的情况下将单元连接在一起。这样可以节省空间，提供恒定的安装ZX，并保持现代的美观外观。新目录和产品列表！R90系列产品目录下载目录607：R90系列FLR产品其他新产品文献：公告9EM-B3：R120调节器公告9EM-B1：D级工业呼吸空气的空气准备目录604：气动产品-精密调节器FRL-SIF-619：精密调节器清洁干燥空气系统的更多信息（PDF）目录：603：烘干机产品：液体分离器，排水阀和制冷干燥机FRL-SIF-618：压缩空气干燥指南FRL-TEC-600：聚碳酸酯碗化学兼容性Wilkerson过滤器，Wilkerson新产品New!90SeriesFRLProductsSafetyLockOutsCombinedSoftStartandRemoteOperatedDumpValveHighPrecisionRegulatorsWSA/WSOSeriesLiquidSeparatorWDV3AutomaticElectricalDrainValveWDV2SeriesZeroLossDrainWDRDSeriesRefrigerationDryerModularBallValveWilkerson过滤器，Wilkerson新产品[详细]

  2018-09-21 10:00

  产品样册

  |

  • 
  • 
  • 
  • 

• BioCheck新产品BC-1303 说明书

  世界ding级实验材料供应商BioCheck正式授权上海起发为其ZG代理，BioCheck在一直是行业的标杆,一直为广大科研客户提供Z为优质的产品和服务,上海起发一直秉承为ZG科研客户带来**的产品，**的服务，签约BioCheck就是为了给广大科研客户带来更加完善的产品和服务,您的满意将是我们Zda的收获BioCheckZG代理,BioCheck上海代理，BioCheck北京代理，BioCheck广东代理，BioCheck江苏代理BioCheck湖北代理,BioCheck天津,BioCheck黑龙江代理,BioCheck内蒙古代理,BioCheck吉林代理,BioCheck福建代理,BioCheck江苏代理,BioCheck浙江代理,BioCheck四川代理BIOCHECK公司由创始人Dr.JohnChen,Medix创立,是一家抓也提供肿瘤标志物，心肌标志物，激素类Z高性价比的抗体的公司。简要原理利用竞争酶联免疫方法，预先在微孔中包被羊抗兔抗体，实验时先后加入氯霉素标准品或待测样本，氯霉素酶标抗原和兔抗氯霉素抗体。经过室温温育，反应液中的兔抗氯霉素抗体与微孔板上的羊抗兔抗体结合，待测样品中的抗原与氯霉素酶标抗原竞争微孔板上的兔抗氯霉素抗体。洗涤后，没有与抗体结合的待测样品中的抗原或酶标抗原被洗去，再加入反应底物，结合的酶标抗原的酶将底物转化为蓝色产物，加入终止液后颜色由蓝色变为黄色。反应完成后，样品中氯霉素含量越多，反应呈色就越浅；反之，样品中氯霉素含量越少，则呈色越深。利用标准曲线可计算出样品中氯霉素含量。技术参数检测蜂蜜、蛋类、牛奶、奶粉、水产品、动物组织(肌肉、肝脏等)、饲料、血清、血浆及尿液样本中存在的氯霉素，定量限可达0.025ppb。No.样品检测下限1蜂蜜0.02ppb(0.02ng/g)2蛋类0.02ppb(0.02ng/g)3牛奶0.002ppb(0.002ng/ml)4奶粉0.012ppb(0.012ng/g)5虾，鱼及肉类0.08ppb(0.08ng/g)6饲料0.08ppb(0.08ng/g)7血清/血浆0.02ppb(0.02ng/ml)8尿液0.04ppb(0.04ng/ml)交叉反应名称百分比氯霉素碱0.4%甲基氯霉素<0.04%回收率No.样品回收率1蜂蜜70%~110%2牛奶90%~130%3蛋，虾，鱼及肉类95%~120%4饲料95%~120%5血清/血浆90%~120%6尿液1**%~130%PD-L1ENZYMEIMMUNOASSAYTESTKITCatalogNumber:BC-1303EnzymeImmunoassayfortheQuantitativeDeterminationofPD-L1ConcentrationinHumanSerumandPlasmaFORRESEARCHUSEONLYNotforuseindiagnosticproceduresINTRODUCTIONProgrammeddeathreceptor-ligand1(PD-L1,B7-H1,CD274)isabiomarkerfromtheB7familythatisexpressedonavarietyofcellsandupregulatedinresponsetopro-inflammatorycytokinessuchasinterferongamma1,2,3.PD-L1interactswithPD-1,aco-receptorexpressedbyexhaustedTcells,toencourageanimmunosuppressivetumormicroenvironmentbydecreasingTcellreceptormediatedproliferationandcytokineproduction4,5.ThePD-1/PD-L1interactionfunctionsasanimmunecheckpointinaprocessknownasimmunoeditingwherethehostimmunesystemeliminateshighlyimmunogenictumorswhileallowinglessimmunogenictumortoevadeit2,6.Multiplesolidtumortypesincludingmelanoma,renalcellcarcinoma,non-smallcelllungcancer,ovarian,andcolorectalcancerutilizethisPD-1/PD-L1immunoeditingmechanism2.CurrenttreatmenthasfocusedonblockingthePD-1/PD-L1interactiontoreducetumorevasionbyinhibitingPD-1,withnewfocusonPD-L1aswell1,2.PRINCIPLEOFTHEASSAYThePD-L1ELISAisbasedontheprincipleofasolidphaseenzyme-linkedimmunosorbentassay.TheassaysystemutilizesauniquemonoclonalantibodypairdirectedagainstadistinctantigenicdeterminantonthePD-L1molecule.Onemousemonoclonalanti-PD-L1antibodyisusedforsolidphaseimmobilization(onthemicrotiterwells).Anothermousemonoclonalanti-PD-L1antibodyconjugatedtohorseradishperoxidase(HRP)isintheenzymeconjugatesolution.Thetestsamplesareallowedtoreactsequentiallywiththetwoantibodies,resultinginthePD-L1moleculestobesandwichedbetweenthesolidphaseandenzyme-linkedantibodies.Aftertwoseparate60-minuteincubationstepsatroomtemperature,thewellsarerinsedwithWashBuffertoremoveunboundlabeledantibodies.TMBReagentisaddedandincubatedfor30minutesunderdarkconditions,resultinginthedevelopmentofabluecolor.ThecolordevelopmentisstoppedwiththeadditionofStopSolution,changingthecolortoyellow.TheconcentrationofPD-L1isdirectlyproportionaltothecolorintensityofthetestsamples.Absorbanceismeasuredspectrophotometricallyat450nm.REAGENTSANDMATERIALSPROVIDEDAntibody-CoatedWells(1plate,96wells)Microtiterwellscoatedwithmousemonoclonalanti-PD-L120ng/mlPD-L1Standard(0.5mL/vial)20ng/mLPD-L1inphosphatebuffer-BSAsolutionwithpreservatives3.StandardandSampleDiluent(30mL/bottle,1bottle)Containsphosphatebuffer-BSAsolutionwithpreservativesEnzymeConjugateReagent(12mL/vial,1vial)Containsmousemonoclonalanti-PD-L1conjugatedtohorseradishperoxidase20XWashBuffer(50mL/bottle,1bottle)PhosphatebufferwithdetergentsTMBReagent(11mL/bottle,1bottle)Containsone-stepTMBsolutionStopSolution(11mL/bottle,1bottle)Containsdilutedhydrochloricacid(1NHCl)STORAGECONDITIONSStoretheunopenedkitat2-8°Cuponreceiptandwhenitisnotinuse,untiltheexpirationshownonthekitlabel.Refertothepackagelabelfortheexpirationdate.Keepmicrotiterplateinasealedbagwithdesiccanttominimizeexposuretodampair.REAGENTPREPARATIONAllreagents首ldbeallowedtoreachroomtemperature(18-25°C)beforeuse.Foreachtestrun,prepareafreshstandardset.Dilute20ng/mLstandardto5ng/mL.Preparetwo-foldserialdilutionsofthe5ng/mLStandardwithStandard/SampleDiluent:5ng/mL:0.15mLof20ng/mL+0.45mLofStandard/SampleDiluent2.5ng/mL:0.25mLof5ng/mL+0.25mLofStandard/SampleDiluent1.25ng/mL:0.25mLof2.5ng/ml+0.25mLofStandard/SampleDiluent0.625ng/mL:0.25mLof1.25ng/mL+0.25mLofStandard/SampleDiluent0.313ng/mL:0.25mLof0.625ng/mL+0.25mLofStandard/SampleDiluent0.156ng/mL:0.25mLof0.313ng/mL+0.25mLofStandardDiluent0.078ng/mL:0.25mLof0.156ng/mL+0.25mLofStandardDiluent0ng/mL:0.25mLofStandardDiluentPatientsamplesneedtobediluted4-foldpriortouse.Prepareaseriesofsmalltubes(i.e.,1.5mLmicrocentrifugetubes)andmix60Lofserumwith180LStandard/SampleDiluent.WorkingWashBuffer:Preparationof1XWashBufferfrom20XStock.Add50mLof20XWashBufferStockto950mLofDIH2O.TheWorkingWashBufferisstableat2-8°Cfor30days.NOTE:Anycrystalsthatmaybepresentduetohighsaltconcentrationmustberedissolvedatroomtemperaturebeforemakingthedilution.ASSAYPROCEDUREPrepareStandards.SeeReagentPreparation.Dilutesamples1:4dilution.SeeReagentPreparation.Securethedesirednumberofcoatedwellsintheholder.Dispense100mLofPD-L1standards,andDILUTEDspecimensintotheappropriatewells.Incubatefor60minutesatroomtemperature(18-25°C).Removeincubationmixturebyflickingplatecontentsintoawastecontainer.Rinseandflickthemicrotiterwells5timeswith300mLWorkingWashBuffer.Strikethewellsontoabsorbentpaperorpapertowelstoremoveallresidualwaterdroplets.Dispense100mLofPD-L1WorkingEnzymeConjugateReagentintoeachwell.Incubatefor60minutesatroomtemperature(18-25°C).Removeincubationmixturebyflickingplatecontentsintoawastecontainer.Rinseandflickthemicrotiterwells5timeswith300uLWorkingWashBuffer.Strikethewellsontoabsorbentpaperorpapertowelstoremoveallresidualwaterdroplets.Dispense100mLTMBsolutionintoeachwell.Incubatefor30minutesatroomtemperature(18-25°C).Stopthereactionbyadding100mLofStopSolutionintoeachwell.Gentlymixfor30seconds.Itisimportanttomakesurethatallthebluecolorchangestoyellowcolorcompletely.Readabsorbanceat450nmwithamicrotiterwellreaderwithin15minutes.CALCULATIONOFRESULTSCalculatethemeanabsorbancevalue(OD450)foreachsetofreferencestandards,controlsandsamples.Constructastandardcurvebyplottingthemeanabsorbanceobtainedforeachreferencestandardagainstitsconcentrationinng/mlongraphpaper,withabsorbanceonthevertical(y)axisandconcentrationonthehorizontal(x)axis.ThecorrespondingconcentrationofPD-L1(ng/mL)canbedeterminedfromthestandardcurveusingthemeanabsorbancevalueforeachsample.Dependingonexperienceand/ortheavailabilityofcomputercapability,othermethodsofdatareductionmaybeemployed.Theobtainedvaluesofthesamples首ldbemultipliedbythedilutionfactorof4toobtainPD-L1resultsinng/ml.EXAMPLEOFSTANDARDCURVEResultsofatypicalstandardrunwithabsorbencyreadingsat450nmshownontheYaxisagainstPD-L1concentrationsshownontheXaxis.NOTE:Thisstandardcurveisforthepurposeofillustrationonly,and首ldnotbeusedtocalculateunknowns.Eachlaboratorymustgenerateitsowndataandstandardcurveineachexperiment.PD-L1Absorbance(ng/ml)(450nm)00.0420.0780.1410.1560.2360.3130.4150.6250.7261.251.2832.52.10053.053nm3.53(4502.52Absorbance1.510.50012345PD-L1Conc.(ng/ml)PERFORMANCECHARACTERISTICSSensitivityTheminimumdetectableconcentrationofthePD-L1ELISAassayasmeasuredby2SDfromthemeanofazerostandardisestimatedtobe0.02ng/ml.PrecisionIntra-AssayPrecisionWithin-runprecisionwasdeterminedbyreplicatedeterminationsofthreedifferentsamplesinoneassay.Within-assayvariabilityisshownbelow:Sample123#Replicates242424MeanPD-L1(ng/mL)1.53.07.4S.D.0.040.050.18C.V.(%)2.4%1.6%2.4%2Inter-AssayPrecisionBetween-runprecisionwasdeterminedbyreplicatemeasurementsofthreedifferentsamplesoveraseriesofindividuallycalibratedassays.Between-assayvariabilityisshownbelow:Sample123#Replicates202020MeanPD-L1(ng/mL)1.63.07.4S.D.0.040.120.26C.V.(%)2.5%4.1%3.5%RecoveryandLinearityStudiesRecoverySampleswerespikedwithknownPD-L1levelsandassayedinduplicate.Themeanrecoverywas90%.SampleEXPECTEDOBSERVED%RECOVERY[PD-L1][PD-L1](ng/mL)(ng/mL)121.890%254.692%3108.989%LinearityThreesampleswereseriallydilutedtodeterminelinearity.Themeanrecoverywas110.3%.#DilutionExpectedObservedConc.(ng/ml)Conc.(ng/ml)%Expected1.1:41.61.6N/A1:81.7106.3%1:161.7106.3%1:321.8112.5%Mean=108.4%2.1:43.73.7N/A1:84.0108.1%1:164.0108.1%1:324.1110.8%Mean=109.0%3.1:47.47.4N/A1:88.3112.2%1:168.6116.2%1:328.3112.2%Mean=113.5%REFERENCESHerbst,RoyS.,etal."Predictivecorrelatesofresponsetotheanti-PD-L1antibodyMPDL3280Aincancerpatients."Nature515.7528(2014):563.Patel,SandipPravin,andRazelleKurzrock."PD-L1expressionasapredictivebiomarkerincancerimmunotherapy."Molecularcancertherapeutics14.4(2015):847-856.Topalian,SuzanneL.,CharlesG.Drake,andDrewM.Pardoll."TargetingthePD-1/B7-H1(PD-L1)pathwaytoactivateanti-tumorimmunity."Currentopinioninimmunology24.2(2012):207-212.Blank,Christian,andAndreasMackensen."ContributionofthePD-L1/PD-1pathwaytoT-cellexhaustion:anupdateonimplicationsforchronicinfectionsandtumorevasion."Cancerimmunology,immunotherapy56.5(2007):739-745.Barber,DanielL.,etal."RestoringfunctioninexhaustedCD8Tcellsduringchronicviralinfection."Nature439.7077(2006):682.Teng,MicheleWL,etal."ClassifyingcancersbasedonT-cellinfiltrationandPD-L1."Cancerresearch75.11(2015):2139-2145.部分Zxin产品如下：货号品名Tests/Kit规格品牌70748MouseMonoclonalanti-humanPD-1(Capture)Purified0.1/0.5/1mgBioCheck70749MouseMonoclonalanti-humanPD-1(Capture)Purified0.1/0.5/1mgBioCheck70750MouseMonoclonalanti-humanPD-1(Detection)Purified0.1/0.5/1mgBioCheck70751MouseMonoclonalanti-humanPD-L1(Capture)Purified0.1/0.5/1mgBioCheck70752MouseMonoclonalanti-humanPD-L1(Capture)Purified0.1/0.5/1mgBioCheck70753MouseMonoclonalanti-humanPD-L1(Detection)Purified0.1/0.5/1mgBioCheck70745Mousemonoclonalanti-humanLp-PLA2(Capture)Purified0.5mgBioCheck70746Mousemonoclonalanti-humanLp-PLA2(Detection)Purified0.5mgBioCheck70747Mousemonoclonalanti-humanLp-PLA2(Detection)Purified0.5mgBioCheck我们公司Zda优势是强大的采购，1：基本什么都能进口，血清，抗体，耗材，还有部分限制进口的，2：货品全，现经营过700多个品牌，基本所有生物试剂耗材都可以进口，特别是冷偏的产品那就更有优势，3：提供加急服务，一般1-2周到货，超过时限加急费全免4：价格公道，绝大部分价格有优势，当然不能保证1**%产品都是价格Zdi,因为价格Zdi意味着没有服务.5：良好的信誉，大部分客户我们提供货到付款服务，客户包括清华，北大交大复旦，中山等100多所大学，ROCHE，阿斯利康，国药，fisher等500多家公司6：我们du家代理的品牌有：AntibodyResearchCorporation，arcticzymes，Biorelevant，AmberGen,Inc.，clemente-associates，clodronateliposomes，ColumbiaBiosciences，enzymeresearch，GeneBridgesGmbH，Genovis，AmberGen,Inc.BiotechnologyGmbH，HaematologicTechnologiesHTIHaemtech，hookelabs，Immudex，InnovativeResearchofAmerica，inspiralis，ListBiologicalLaboratories,Inc.，lumafluor，Microsurfaces，multiplicom，nanotools，Pel-FreezBiologicals，pentapharm，progen，ProteinArk，QA-Bio,Inc，QA-Bio,IncQuickZymeBiosciences，Teknova，TriLinkBioTechnologies,Inc.，ZyagenLaboratories等7：我们还是invitrogen,qiagen,MidlandBioProductsCorporationam,sigma;neb,roche,merck,rnd,BD,GE,pierce,BioLegend等知名批发，欢迎合作。[详细]

  2018-09-29 10:02

  产品样册

  |

  • 
  • 
  • 
  • 

• BioCheck新产品BC-1301 说明书

  世界ding级实验材料供应商BioCheck正式授权上海起发为其ZG代理，BioCheck在一直是行业的标杆,一直为广大科研客户提供Z为优质的产品和服务,上海起发一直秉承为ZG科研客户带来**的产品，**的服务，签约BioCheck就是为了给广大科研客户带来更加完善的产品和服务,您的满意将是我们Zda的收获BioCheckZG代理,BioCheck上海代理，BioCheck北京代理，BioCheck广东代理，BioCheck江苏代理BioCheck湖北代理,BioCheck天津,BioCheck黑龙江代理,BioCheck内蒙古代理,BioCheck吉林代理,BioCheck福建代理,BioCheck江苏代理,BioCheck浙江代理,BioCheck四川代理BIOCHECK公司由创始人Dr.JohnChen,Medix创立,是一家抓也提供肿瘤标志物，心肌标志物，激素类Z高性价比的抗体的公司。简要原理利用竞争酶联免疫方法，预先在微孔中包被羊抗兔抗体，实验时先后加入氯霉素标准品或待测样本，氯霉素酶标抗原和兔抗氯霉素抗体。经过室温温育，反应液中的兔抗氯霉素抗体与微孔板上的羊抗兔抗体结合，待测样品中的抗原与氯霉素酶标抗原竞争微孔板上的兔抗氯霉素抗体。洗涤后，没有与抗体结合的待测样品中的抗原或酶标抗原被洗去，再加入反应底物，结合的酶标抗原的酶将底物转化为蓝色产物，加入终止液后颜色由蓝色变为黄色。反应完成后，样品中氯霉素含量越多，反应呈色就越浅；反之，样品中氯霉素含量越少，则呈色越深。利用标准曲线可计算出样品中氯霉素含量。技术参数检测蜂蜜、蛋类、牛奶、奶粉、水产品、动物组织(肌肉、肝脏等)、饲料、血清、血浆及尿液样本中存在的氯霉素，定量限可达0.025ppb。No.样品检测下限1蜂蜜0.02ppb(0.02ng/g)2蛋类0.02ppb(0.02ng/g)3牛奶0.002ppb(0.002ng/ml)4奶粉0.012ppb(0.012ng/g)5虾，鱼及肉类0.08ppb(0.08ng/g)6饲料0.08ppb(0.08ng/g)7血清/血浆0.02ppb(0.02ng/ml)8尿液0.04ppb(0.04ng/ml)交叉反应名称百分比氯霉素碱0.4%甲基氯霉素<0.04%回收率No.样品回收率1蜂蜜70%~110%2牛奶90%~130%3蛋，虾，鱼及肉类95%~120%4饲料95%~120%5血清/血浆90%~120%6尿液1**%~130%PD-1ENZYMEIMMUNOASSAYTESTKITCatalogNumber:BC-1301EnzymeImmunoassayfortheQuantitativeDeterminationofPD-1ConcentrationinHumanSerumandPlasmaFORRESEARCHUSEONLYNotforuseindiagnosticproceduresINTRODUCTIONProgrammedcelldeathprotein1,(PD-1,CD279,PDCD1),isacellsurfacereceptorthatiscriticalfortheregulationofTcellinflammatoryactivityandmaintainsperipheraltoleranceintheimmunesystem(1).WithanextracellularIgVdomain,atransmembranedomain,andanintracellulartailwithtwophosphorylationsites(SHP-1andSHP-2),PD-1isabletointeractwithligandsPD-L1andPD-L2todown-regulatetheimmunesystemandsuppressTcellactivity(2).Uponantigenrecognition,anactivatedTcellexpressesPD-1onitssurfaceandproducesinterferons,whichinducesexpressionofPD-L1,therebypromotingapoptosisorcelldeath.(3)Howeverwhenhijackedbytumorcells,aberrantexpressionofPD-1ligandsinhibitsimmune-modulatoryTcellactivation,leadingtodiseaseprogression(4).ElevatedlevelsofPD-1inserumandplasmahavebeenassociatedwithrheumatoidarthritisandskinsclerosis(5,6).Also,PD-1ispredominantlyexpressedbytumorinfiltratingTcells(7).FurtherresearchimpliesthatusingmonoclonalantibodiestotargetthePD-1immunologiccheckpointhascontributedtobreakthroughprogressinunderstandingandtreatingcancerssuchasmelanomaandothervariousnon-smallcelllungcancer(4).PRINCIPLEOFTHEASSAYThePD-1ELISAisbasedontheprincipleofasolidphaseenzyme-linkedimmunosorbentassay.TheassaysystemutilizesauniquemonoclonalantibodypairdirectedagainstadistinctantigenicdeterminantonthePD-1molecule.Onemousemonoclonalanti-PD-1antibodyisusedforsolidphaseimmobilization(onthemicrotiterwells).Anothermousemonoclonalanti-PD-1antibodyconjugatedtohorseradishperoxidase(HRP)isintheenzymeconjugatesolution.Thetestsamplesareallowedtoreactsequentiallywiththetwoantibodies,resultinginthePD-1moleculestobesandwichedbetweenthesolidphaseandenzyme-linkedantibodies.Aftertwoseparate60-minuteincubationstepsatroomtemperature,thewellsarerinsedwithWashBuffertoremoveunboundlabeledantibodies.TMBReagentisaddedandincubatedfor30minutesunderdarkconditions,resultinginthedevelopmentofabluecolor.ThecolordevelopmentisstoppedwiththeadditionofStopSolution,changingthecolortoyellow.TheconcentrationofPD-1isdirectlyproportionaltothecolorintensityofthetestsamples.Absorbanceismeasuredspectrophotometricallyat450nm.REAGENTSANDMATERIALSPROVIDEDAntibody-CoatedWells(1plate,96wells)Microtiterwellscoatedwithmousemonoclonalanti-PD-150ng/mlPD-1Standard(0.5mL/vial)50ng/mLPD-1inphosphatebuffer-BSAsolutionwithpreservatives3.StandardandSampleDiluent(30mL/bottle,1bottle)Containsphosphatebuffer-BSAsolutionwithpreservativesEnzymeConjugateReagent(12mL/vial,1vial)Containsmousemonoclonalanti-PD-1conjugatedtohorseradishperoxidase20XWashBuffer(50mL/bottle,1bottle)PhosphatebufferwithdetergentsTMBReagent(11mL/bottle,1bottle)Containsone-stepTMBsolutionStopSolution(11mL/bottle,1bottle)Containsdilutedhydrochloricacid(1NHCl)STORAGECONDITIONSStoretheunopenedkitat2-8°Cuponreceiptandwhenitisnotinuse,untiltheexpirationshownonthekitlabel.Refertothepackagelabelfortheexpirationdate.Keepmicrotiterplateinasealedbagwithdesiccanttominimizeexposuretodampair.REAGENTPREPARATIONAllreagents首ldbeallowedtoreachroomtemperature(18-25°C)beforeuse.Foreachtestrun,prepareafreshstandardset.Dilute50ng/mLto10ng/mLwithStandard/Samplediluent.Preparetwo-foldserialdilutionsofthe10ng/mLStandardwithStandard/SampleDiluent:10ng/mL:0.12mLof50ng/mL+0.48mLofStandard/SampleDiluent5ng/mL:0.25mLof10ng/mL+0.25mLofStandard/SampleDiluent2.5ng/mL:0.25mLof5ng/mL+0.25mLofStandard/SampleDiluent1.25ng/mL:0.25mLof2.5ng/ml+0.25mLofStandard/SampleDiluent0.625ng/mL:0.25mLof1.25ng/mL+0.25mLofStandard/SampleDiluent0.313ng/mL:0.25mLof0.625ng/mL+0.25mLofStandard/SampleDiluent0.156ng/mL:0.25mLof0.313ng/mL+0.25mLofStandardDiluent0ng/mL:0.25mLofStandardDiluentPatientsamplesneedtobediluted4-foldpriortouse.Prepareaseriesofsmalltubes(i.e.,1.5mLmicrocentrifugetubes)andmix60Lofserumwith180LStandard/SampleDiluent.WorkingWashBuffer:Preparationof1XWashBufferfrom20XStock.Add50mLof20XWashBufferStockto950mLofDIH2O.TheWorkingWashBufferisstableat2-8°Cfor30days.NOTE:Anycrystalsthatmaybepresentduetohighsaltconcentrationmustberedissolvedatroomtemperaturebeforemakingthedilution.ASSAYPROCEDUREPrepareStandards.SeeReagentPreparation.Dilutesamples1:4dilution.SeeReagentPreparation.Securethedesirednumberofcoatedwellsintheholder.Dispense100mLofPD-1standards,andDILUTEDspecimensintotheappropriatewells.Incubatefor60minutesatroomtemperature(18-25°C).Removeincubationmixturebyflickingplatecontentsintoawastecontainer.Rinseandflickthemicrotiterwells5timeswith300mLWorkingWashBuffer.Strikethewellsontoabsorbentpaperorpapertowelstoremoveallresidualwaterdroplets.Dispense100mLofPD-1WorkingEnzymeConjugateReagentintoeachwell.Incubatefor60minutesatroomtemperature(18-25°C).Removeincubationmixturebyflickingplatecontentsintoawastecontainer.Rinseandflickthemicrotiterwells5timeswith300uLWorkingWashBuffer.Strikethewellsontoabsorbentpaperorpapertowelstoremoveallresidualwaterdroplets.Dispense100mLTMBsolutionintoeachwell.Incubatefor30minutesatroomtemperature(18-25°C).Stopthereactionbyadding100mLofStopSolutionintoeachwell.Gentlymixfor30seconds.Itisimportanttomakesurethatallthebluecolorchangestoyellowcolorcompletely.Readabsorbanceat450nmwithamicrotiterwellreaderwithin15minutes.CALCULATIONOFRESULTSCalculatethemeanabsorbancevalue(OD450)foreachsetofreferencestandards,controlsandsamples.Constructastandardcurvebyplottingthemeanabsorbanceobtainedforeachreferencestandardagainstitsconcentrationinng/mlongraphpaper,withabsorbanceonthevertical(y)axisandconcentrationonthehorizontal(x)axis.ThecorrespondingconcentrationofPD-1(ng/mL)canbedeterminedfromthestandardcurveusingthemeanabsorbancevalueforeachsample.Dependingonexperienceand/ortheavailabilityofcomputercapability,othermethodsofdatareductionmaybeemployed.Theobtainedvaluesofthesamples首ldbemultipliedbythedilutionfactorof4toobtainPD-1resultsinng/ml.EXAMPLEOFSTANDARDCURVEResultsofatypicalstandardrunwithabsorbencyreadingsat450nmshownontheYaxisagainstPD-1concentrationsshownontheXaxis.NOTE:Thisstandardcurveisforthepurposeofillustrationonly,and首ldnotbeusedtocalculateunknowns.Eachlaboratorymustgenerateitsowndataandstandardcurveineachexperiment.PD-1Absorbance(ng/ml)(450nm)00.0890.1560.1380.3130.1900.6250.2841.250.4812.50.85151.581102.776nm32.5(4502Absorbance1.510.500246810PD-1Conc.(ng/ml)PERFORMANCECHARACTERISTICSSensitivityTheminimumdetectableconcentrationofthePD-1ELISAassayasmeasuredby2SDfromthemeanofazerostandardisestimatedtobe0.15ng/ml.PrecisionIntra-AssayPrecisionWithin-runprecisionwasdeterminedbyreplicatedeterminationsofthreedifferentsamplesinoneassay.Within-assayvariabilityisshownbelow:Sample123#Replicates242424MeanPD-1(ng/mL)8.413.222.9S.D.0.61.00.9C.V.(%)7.0%7.2%3.8%.2Inter-AssayPrecisionBetween-runprecisionwasdeterminedbyreplicatemeasurementsofthreedifferentsamplesoveraseriesofindividuallycalibratedassays.Between-assayvariabilityisshownbelow:Sample123#Replicates202020MeanPD-1(ng/mL)9.113.525.3S.D.0.81.10.9C.V.(%)9.2%7.93.7RecoveryandLinearityStudiesRecoverySampleswerespikedwithknownPD-1levelsandassayedinduplicate.Themeanrecoverywas105.3%.PAIREXPECTEDOBSERVED%RECOVERYNUMBER[PD-1][PD-1](ng/mL)(ng/mL)188.8110.0%212.513.1104.8%32525.3101.2%LinearityThreesampleswereseriallydilutedtodeterminelinearity.Themeanrecoverywas99.6%.#DilutionExpectedObservedConc.(ng/ml)Conc.(ng/ml)%Expected1.1:210.1114.8%1:48.88.8N/A1:87.888.6%Mean=101.7%2.1:214.5110.6%1:413.113.1N/A1:811.688.5%Mean=99.6%3.1:226.5104.7%1:425.325.3N/A1:823.090.0%Mean=97.4%REFERENCESFife,B.T.,&Pauken,K.E.(2011).TheroleofthePD-1pathwayinautoimmunityandperipheraltolerance.AnnalsoftheNewYorkAcademyofSciences,1217(1),45-59.Riella,L.V.,Paterson,A.M.,Sharpe,A.H.,&Chandraker,A.(2012).RoleofthePD-1PathwayintheImmuneResponse.AmericanJournalofTransplantation:OfficialJournaloftheAmericanSocietyofTransplantationandtheAmericanSocietyofTransplantSurgeons,12(10),25752587.Zak,Krzysztof&Kitel,Radosaw&Przetocka,Sara&Golik,Przemysaw&Guzik,Katarzyna&Musielak,Bogdan&Dm领,Alexander&Dubin,Grzegorz&Holak,Tad.(2015).StructureoftheComplexofHumanProgrammedDeath1,PD-1,andItsLigandPD-L1.Structure.23..10.1016/j.str.2015.09.010.ZoranGatalica,CarrieSnyder,ToddManey,AnatoleGhazalpour,DanielHolterman,NianqingXiao,PeggyOverberg,IngaRose,GargiD.Basu,SemirVranic,HenryT.Lynch,DanielD.VonHoffandOmidHamid.ProgrammedCellDeath1(PD-1)andItsLigand(PD-L1)inCommonCancersandTheirCorrelationwithMolecularCancerType.CancerEpidemiolBiomarkersPrev.December12014(23)(12)2965-2970.Greisen,S.,Rasmussen,T.,Stengaard-Pedersen,K.,Hetland,M.,Hrslev-Petersen,K.,Hvid,M.,&Deleuran,B.(2013).Increasedsolubleprogrammeddeath-1(sPD-1)isassociatedwithdiseaseactivityandradiographicprogressioninearlyrheumatoidarthritis.ScandinavianJournalofRheumatology,43(2),101-108.Yanaba,K.,Hayashi,M.,Yoshihara,Y.,&Nakagawa,H.(2016).Serumlevelsofsolubleprogrammeddeath-1andprogrammeddeathligand-1insystemicsclerosis:Associationwithextentofskinsclerosis.TheJournalofDermatology,43(8),954-957.Ahmadzadeh,M.,Johnson,L.A.,Heemskerk,B.,Wunderlich,J.R.,Dudley,M.E.,White,D.E.,&Rosenberg,S.A.(2009).TumorantigenspecificCD8TcellsinfiltratingthetumorexpresshighlevelsofPD-1andarefunctionallyimpaired.Blood,114(8),15371544.部分产品Zxin报价如下：货号品名规格价格品牌BC-1009AFPEIAKitkit3980BioCheckBC-1011CEAEIAKitkit4016BioCheckBC-1013CA125EIAKitkit4970BioCheckBC-1015CA15-3EIAKitkit4970BioCheckBC-1017CA19-9EIAKitkit4970BioCheckBC-1019PSAEIAKit*kit3962BioCheckBC-1021FreePSAEIAKit*kit4196BioCheckBC-1023Freeb-hCGEIAKitkit4196BioCheckBC-1061b-2MicroglobulinEIAKit§kit4250BioCheckBC-1001TSHEIAKit§kit3800BioCheckBC-1003U-TSH(S-TSH)EIAKit§kit3800BioCheckBC-1005T3EIAKit§kit3656BioCheckBC-1006FreeT3EIAKit§kit3890BioCheckBC-1007T4EIAKit§kit3656BioCheckBC-1008FreeT4EIAKitkit3890BioCheckBC-1081RubellaIgGEIAKit*kit4106BioCheckBC-1083RubellaIgMEIAKit*kit4196BioCheckBC-1085ToxoIgGEIAKit*kit3980BioCheckBC-1087ToxoIgMEIAKit*kit4070BioCheckBC-1089CMVIgGEIAKit*kit3980BioCheckBC-1091CMVIgMEIAKit*kit4070BioCheckBC-1093HSVIIgGEIAKitkit3980BioCheckBC-1095HSVIIgMEIAKitkit4196BioCheckBC-1097HSVIIIgGEIAKitkit3980BioCheckBC-1099HSVIIIgMEIAKitkit4070BioCheckBC-1051H.pyloriIgG(Qualitative)EIAKitkit4016BioCheckBC-1052H.pyloriIgG(Quantitative)EIAKitkit4106BioCheckBC-1053H.pyloriIgM(Qualitative)EIAKitkit4286BioCheckBC-1027hCGEIAKit§kit3800BioCheckBC-1029FSHEIAKit§kit3800BioCheckBC-1031LHEIAKit§kit3800BioCheckBC-1037ProlactinEIAKit§kit3800BioCheckBC-1025HumanFerritinEIAKit§kit3800BioCheckBC-1033HGHEIAKit§kit3800BioCheckBC-1035IgEEIAKit§kit3800BioCheckBC-1203AdiponectinEIAKit*kit7580BioCheckBC-1105TroponinIEIAKit§kit5330BioCheckBC-1117MyoglobinEIAKit§kit4250BioCheckBC-1119HS-CRPEIAKit§kit4250BioCheckBC-1121CK-MBEIAKit*kit6680BioCheckBC-1129MPOEIAKit*kit8480BioCheckBC-1111EstradiolEIAKit§kit4250BioCheckBC-1113ProgesteroneEIAKit§kit4250BioCheckBC-1115TestosteroneEIAKit§kit4250BioCheck我们公司Zda优势是强大的采购，1：基本什么都能进口，血清，抗体，耗材，还有部分限制进口的，2：货品全，现经营过700多个品牌，基本所有生物试剂耗材都可以进口，特别是冷偏的产品那就更有优势，3：提供加急服务，一般1-2周到货，超过时限加急费全免4：价格公道，绝大部分价格有优势，当然不能保证1**%产品都有价格优势，5：良好的信誉，大部分客户我们提供货到付款服务，客户包括清华，北大交大复旦，中山等100多所大学，ROCHE，阿斯利康，国药，fisher等500多家公司6：我们还是santa,AdvancedBiotechnologiesInc;AthensResearch&Technology,bangs,BBInternational,crystalchem,dianova,FDNeurotechnologies,Inc.FormuMaxScientific,Inc;Genebridege;GlycotopeBiotechnologyGmbH;iduron;InnovativeResearchofAmerica；Ludger；neuroprobe;omicronbio;Polysciences;prospecbi;QA-BIO；quickzyme；RESEARCHDIETS,INC；sterlitech；sysy；TriLinkBioTechnologies,Inc；BIOCHECKINC-biochem;zyagen;......几十家国外公司授权代理7：我们还从事invitrogen，qiagen;abcam;sigma;neb;roche;merck;rnd;BD;GE;pierce;BioLegend....等批发[详细]

  2018-09-29 10:02

  产品样册

  |

  • 
  • 
  • 
  • 

• h-h-c 新产品 NATRSV-6C 说明书

  世界ding级实验材料供应商HelveticaHealthCare正式授权上海起发为其ZG代理，HelveticaHealthCare在一直是行业的标杆,一直为广大科研客户提供Z为优质的产品和服务,上海起发一直秉承为ZG科研客户带来**的产品，**的服务，签约HelveticaHealthCare就是为了给广大科研客户带来更加完善的产品和服务,您的满意将是我们Zda的收获HelveticaHealthCareZG代理,HelveticaHealthCare上海代理，HelveticaHealthCare北京代理，HelveticaHealthCare广东代理，HelveticaHealthCare江苏代理HelveticaHealthCare湖北代理,HelveticaHealthCare天津,HelveticaHealthCare黑龙江代理,HelveticaHealthCare内蒙古代理,HelveticaHealthCare吉林代理,HelveticaHealthCare福建代理,HelveticaHealthCare江苏代理,HelveticaHealthCare浙江代理,HelveticaHealthCare四川代理,HelveticaHealthCare是一家广泛的YL保健公司，致力于与客户合作，提供创新的产品和技术来管理健康和提高生活质量。我们专注于研究产品和诊断，ZD关注用于核酸测试的分子控制和校准器。我们为许多商业分子系统提供控制。我们还可以获得大量的临床标本，并可以提供来自HIV，HCV和HBV无症状供体的多种血清转化材料。我们公司位于瑞士，在日内瓦，在欧洲心脏地区的国际城市，以生活质量和高水平的专业精神而着称。我们位于瑞士生物瓦伦西亚，为科学研究和开发提供了高度的定位环境。世界上许多领xian的制药公司和非政府组织（包括世界卫生组织）在内的很近。我们经验丰富的团队在我们的实践和透明的业务方法中反映了这些价值我们致力于追求zhuo越，产品质量和可靠性，合作伙伴的选择以及我们为客户提供的个性化服务。NATtrolRSVPositiveControlNATtrolRSV阳性对照产品编号：NATRSV-6C产品描述平台：造父亲GeneXpert;测试：RSV-FLUA/B/+2°至+8°C附加信息重量0.003公斤单位体积6x0.5ml相关产品NATtrol艰难梭菌阴性对照硝基葡萄球菌MSSA;-mecA，外部运行控制，低NATtrol流感A/B阳性对照NATtrolEBV控制目标：10,000cp-ml[详细]

  2018-10-06 10:00

  产品样册

  |

  • 
  • 
  • 
  • 

• h-h-c 新产品 NATFLUAB-6C 说明书

  世界ding级实验材料供应商HelveticaHealthCare正式授权上海起发为其ZG代理，HelveticaHealthCare在一直是行业的标杆,一直为广大科研客户提供Z为优质的产品和服务,上海起发一直秉承为ZG科研客户带来**的产品，**的服务，签约HelveticaHealthCare就是为了给广大科研客户带来更加完善的产品和服务,您的满意将是我们Zda的收获HelveticaHealthCareZG代理,HelveticaHealthCare上海代理，HelveticaHealthCare北京代理，HelveticaHealthCare广东代理，HelveticaHealthCare江苏代理HelveticaHealthCare湖北代理,HelveticaHealthCare天津,HelveticaHealthCare黑龙江代理,HelveticaHealthCare内蒙古代理,HelveticaHealthCare吉林代理,HelveticaHealthCare福建代理,HelveticaHealthCare江苏代理,HelveticaHealthCare浙江代理,HelveticaHealthCare四川代理,HelveticaHealthCare是一家广泛的YL保健公司，致力于与客户合作，提供创新的产品和技术来管理健康和提高生活质量。我们专注于研究产品和诊断，ZD关注用于核酸测试的分子控制和校准器。我们为许多商业分子系统提供控制。我们还可以获得大量的临床标本，并可以提供来自HIV，HCV和HBV无症状供体的多种血清转化材料。我们公司位于瑞士，在日内瓦，在欧洲心脏地区的国际城市，以生活质量和高水平的专业精神而着称。我们位于瑞士生物瓦伦西亚，为科学研究和开发提供了高度的定位环境。世界上许多领xian的制药公司和非政府组织（包括世界卫生组织）在内的很近。我们经验丰富的团队在我们的实践和透明的业务方法中反映了这些价值我们致力于追求zhuo越，产品质量和可靠性，合作伙伴的选择以及我们为客户提供的个性化服务。NATtrolInfluenzaA/BPositiveControlNATtrol流感A/B阳性对照产品编号：NATFLUAB-6C产品描述平台：GeneXpert;测试：FLUA/B-RSV/+2°至+8°C。附加信息重量0.003公斤单位体积6x0.5ml相关产品MixedTiterBacteriaPanelforPlateletsNATtrolN.gonorrhoeaePositiveControlNATtrolEBVControlTarget:10,000cpmlNATtrolStaphylococcusaureus(MRSA)ExternalRunControl-Medium[详细]

  2018-10-06 10:00

  产品样册

  |

  • 
  • 
  • 
  • 

• h-h-c 新产品 NATCXVA9-6C 说明书

  世界ding级实验材料供应商HelveticaHealthCare正式授权上海起发为其ZG代理，HelveticaHealthCare在一直是行业的标杆,一直为广大科研客户提供Z为优质的产品和服务,上海起发一直秉承为ZG科研客户带来**的产品，**的服务，签约HelveticaHealthCare就是为了给广大科研客户带来更加完善的产品和服务,您的满意将是我们Zda的收获HelveticaHealthCareZG代理,HelveticaHealthCare上海代理，HelveticaHealthCare北京代理，HelveticaHealthCare广东代理，HelveticaHealthCare江苏代理HelveticaHealthCare湖北代理,HelveticaHealthCare天津,HelveticaHealthCare黑龙江代理,HelveticaHealthCare内蒙古代理,HelveticaHealthCare吉林代理,HelveticaHealthCare福建代理,HelveticaHealthCare江苏代理,HelveticaHealthCare浙江代理,HelveticaHealthCare四川代理,HelveticaHealthCare是一家广泛的YL保健公司，致力于与客户合作，提供创新的产品和技术来管理健康和提高生活质量。我们专注于研究产品和诊断，ZD关注用于核酸测试的分子控制和校准器。我们为许多商业分子系统提供控制。我们还可以获得大量的临床标本，并可以提供来自HIV，HCV和HBV无症状供体的多种血清转化材料。我们公司位于瑞士，在日内瓦，在欧洲心脏地区的国际城市，以生活质量和高水平的专业精神而着称。我们位于瑞士生物瓦伦西亚，为科学研究和开发提供了高度的定位环境。世界上许多领xian的制药公司和非政府组织（包括世界卫生组织）在内的很近。我们经验丰富的团队在我们的实践和透明的业务方法中反映了这些价值我们致力于追求zhuo越，产品质量和可靠性，合作伙伴的选择以及我们为客户提供的个性化服务。NATtrolInfluenza/RSVNegativeControlNATtrol流感/RSV阴性对照产品编号：NATCXVA9-6C产品描述平台：造父亲GeneXpert;测试：FLUA/B-RSV/+2°至+8°C。附加信息重量0.003公斤单位体积6x0.5ml相关产品NATtrolMRSAPositiveControlNATtrolClostridiumdifficileNegativeControlNATtrolSalmonellatyphimurium(StoolMatrix)NATtrolSAPositiveControl我们公司Zda优势是强大的采购，1：基本什么都能进口，血清，抗体，耗材，还有部分限制进口的，2：货品全，现经营过700多个品牌，基本所有生物试剂耗材都可以进口，特别是冷偏的产品那就更有优势，3：提供加急服务，一般1-2周到货，超过时限加急费全免4：价格公道，绝大部分价格有优势，当然不能保证1**%产品都是价格Zdi,因为价格Zdi意味着没有服务.5：良好的信誉，大部分客户我们提供货到付款服务，客户包括清华，北大交大复旦，中山等100多所大学，ROCHE，阿斯利康，国药，fisher等500多家公司6：我们du家代理的品牌有：AntibodyResearchCorporation，arcticzymes，Biorelevant，AmberGen,Inc.，clemente-associates，clodronateliposomes，ColumbiaBiosciences，enzymeresearch，GeneBridgesGmbH，Genovis，AmberGen,Inc.BiotechnologyGmbH，HaematologicTechnologiesHTIHaemtech，hookelabs，Immudex，InnovativeResearchofAmerica，inspiralis，ListBiologicalLaboratories,Inc.，lumafluor，Microsurfaces，multiplicom，nanotools，Pel-FreezBiologicals，pentapharm，progen，ProteinArk，QA-Bio,Inc，QA-Bio,IncQuickZymeBiosciences，Teknova，TriLinkBioTechnologies,Inc.，ZyagenLaboratories等7：我们还是invitrogen,qiagen,MidlandBioProductsCorporationam,sigma;neb,roche,merck,rnd,BD,GE,pierce,BioLegend等知名批发，欢迎合作。[详细]

  2018-10-06 10:00

  产品样册

  |

  • 
  • 
  • 
  • 

• 国家ZD新产品证书

  国家ZD新产品证书[详细]

  2024-09-14 11:32

  安装说明

  |

  • 
  • 
  • 
  •